3E BIOVENTURES
3E Bioventures Capital is a healthcare focused venture investment fund. The core 3E investment team members are all trained in biomedical fields, with healthcare industry experience and years of successful investment or entrepreneurship experience in China. The 3E team combines good global industry perspectives with practical on the ground China experiences, the teamโs past investment portfolio companies cover areas such as drug, device, diagnostics, healthcare IT and medical services. 3E Biov... entures Capital currently manages both RMB and US Dollar funds, investing in early and growing stage companies in China and overseas. They believe in the huge industry growth and significant investment opportunities in China healthcare space for the next 10 to 20 years. They aim to leverage their healthcare expertise and experience to ride this historic opportunity, to help build successful healthcare ventures and technologies, to generate good return for their investors, and at the same time, to build 3E Bioventures into a significant international healthcare investment brand.
3E BIOVENTURES
Social Links:
Founded:
2015-01-01
Status:
Active
Contact:
(810) 123 4567
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apache GlobalSign GlobalSign Domain Verification Alibaba HiChina DNS
Similar Organizations
Quest Ventures
Quest Ventures is a top venture capital firm in Asia.
Samsung Ventures
Samsung Ventures is a venture capital firm specializing in investments in start-up companies.
Side Door Ventures
Side Door Ventures is a venture capital firm specializing in pre-seed through Series B startup investments.
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-08-15 | Regenacy Pharmaceuticals | 3E Bioventures investment in Series B - Regenacy Pharmaceuticals | 9.3 M USD |
2022-03-03 | CytoNiche | 3E Bioventures investment in Series B - CytoNiche | 300 M CNY |
2022-02-03 | Dewpoint Therapeutics | 3E Bioventures investment in Series C - Dewpoint Therapeutics | 150 M USD |
2022-01-18 | Dermaliq Therapeutics | 3E Bioventures investment in Series A - Dermaliq Therapeutics | 15 M USD |
2021-12-29 | Zhengli Technology | 3E Bioventures investment in Venture Round - Zhengli Technology | N/A |
2021-12-09 | Boaoxin | 3E Bioventures investment in Venture Round - Boaoxin | 200 M CNY |
2021-12-01 | ITabMed | 3E Bioventures investment in Series A - ITabMed | 20 M USD |
2021-11-16 | Novlead Biotech | 3E Bioventures investment in Series B - Novlead Biotech | 120 M CNY |
2021-09-13 | Alebund Pharmaceuticals | 3E Bioventures investment in Series B - Alebund Pharmaceuticals | 54.5 M USD |
2021-08-29 | NeuralGalaxy | 3E Bioventures investment in Series A - NeuralGalaxy | 500 M CNY |